Vident Advisory, LLC Sarepta Therapeutics, Inc. Transaction History

Vident Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $2,153 - $3,113	-19 Reduced 0.9%	2,100 $332 Million
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $16,866 - $25,475	-180 Reduced 7.83%	2,119 $274 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $17,837 - $33,061	265 Added 13.03%	2,299 $222 Million
Q3 2023 Feb 21, 2024	SELL	$102.5 - $123.59 $27,162 - $32,751	-265 Reduced 11.53%	2,034 $247 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $208,485 - $251,382	2,034 New	2,034 $247 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.